Amelioration of LPS-induced inflammation response in microglia by AMPK activation

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chen, Chin Chen ^a   Lin, Jiun Tsai ^b   Cheng, Yi Fang ^b   Kuo, Cheng Yi ^b   Huang, Chun Fang ^b   Kao, Shao Hsuan ^c   Liang, Yao Jen ^a   Cheng, Ching Yi ^d   Chen, Han Min ^a,b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b ENERGENESIS BIOMEDICAL CO LTD   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 5' MONOPHOSPHATE ACTIVATED PROTEIN KINASE; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; ENERGI F 704; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN KINASE; PURINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG CYTOTOXICITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; INFLAMMATION; MICROGLIA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING; XTT ASSAY; BIOSYNTHESIS; CELL LINE; CHEMICALLY INDUCED; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENERGY METABOLISM; GENETICS; HUMAN; METABOLISM; SASA; TOXICITY; TRANSCRIPTION INITIATION;

AMP-ACTIVATED PROTEIN KINASES; CELL LINE; DINOPROSTONE; ENERGY METABOLISM; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICROGLIA; NITRIC OXIDE; PLANT EXTRACTS; SASA; TRANSCRIPTIONAL ACTIVATION;

EID: 84904136112     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/692061     Document Type: Article

References (36)

1. Holmes C., Cunningham C., Zotova E., Woolford J., Dean C., Kerr S., Culliford D., Perry V. H., Systemic inflammation and disease progression in Alzheimer disease. Neurology 2009 73 10 768 774 2-s2.0-70349570588 10.1212/WNL.0b013e3181b6bb95
2. Gao H.-M., Liu B., Zhang W., Hong J.-S., Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. FASEB Journal 2003 17 13 1957 1959 2-s2.0-84863135790 10.1096/fj.03-0203fje
3. Luo X.-G., Ding J.-Q., Chen S.-D., Microglia in the aging brain: relevance to neurodegeneration. Molecular Neurodegeneration 2010 5 1, article 12 2-s2.0-77950826971 10.1186/1750-1326-5-12
4. Liu B., Hong J.-S., Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. Journal of Pharmacology and Experimental Therapeutics 2003 304 1 1 7 2-s2.0-0037215645 10.1124/jpet.102.035048 (Pubitemid 36008905)
5. Kreutzberg G. W., Microglia: a sensor for pathological events in the CNS. Trends in Neurosciences 1996 19 8 312 318 2-s2.0-0030222037 10.1016/0166-2236(96)10049-7 (Pubitemid 26349059)
6. Bal-Price A., Brown G. C., Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. Journal of Neuroscience 2001 21 17 6480 6491 2-s2.0-0035449358 (Pubitemid 32781092)
7. Yuan L., Neufeld A. H., Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000 32 42 50
8. Schlomann U., Rathke-Hartlieb S., Yamamoto S., Jockusch H., Bartsch J. W., Tumor necrosis factor α induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration. Journal of Neuroscience 2000 20 21 7964 7971 2-s2.0-0034332481
9. Hemmer K., Fransen L., Vanderstichele H., Vanmechelen E., Heuschling P., An in vitro model for the study of microglia-induced neurodegeneration: involvement of nitric oxide and tumor necrosis factor- α Neurochemistry International 2001 38 7 557 565 2-s2.0-0035372340 10.1016/S0197-0186(00)00119-4 (Pubitemid 32268620)
10. Figiel I., Dzwonek K., TNF α and TNF receptor 1 expression in the mixed neuronal-glial cultures of hippocampal dentate gyrus exposed to glutamate or trimethyltin. Brain Research 2007 1131 1 17 28 2-s2.0-33846005877 10.1016/j.brainres.2006.10.095 (Pubitemid 46053896)
11. Ferrari C. C., Pott Godoy M. C., Tarelli R., Chertoff M., Depino A. M., Pitossi F. J., Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1 β in the substantia nigra. Neurobiology of Disease 2006 24 1 183 193 2-s2.0-33748973074 10.1016/j.nbd.2006.06.013 (Pubitemid 44437611)
12. Quintanilla R. A., Orellana D. I., González-Billault C., Maccioni R. B., Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Experimental Cell Research 2004 295 1 245 257 2-s2.0-1642420308 10.1016/j.yexcr.2004.01.002 (Pubitemid 38407361)
13. Barnes P. J., Karin M., Nuclear factor- B-a pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine 1997 336 15 1066 1071 2-s2.0-0030615201 10.1056/NEJM199704103361506 (Pubitemid 27163860)
14. García-Ospina G. P., Jiménez-Del Río M., Lopera F., Vélez-Pardo C., Neuronal DNA damage correlates with a positive detection of c-Jun, nuclear factor B, p53 and Par-4 transcription factors in Alzheimer's disease. Revista de Neurologia 2003 36 11 1004 1010 2-s2.0-0041304626 (Pubitemid 36899381)
15. Hunot S., Brugg B., Ricard D., Michel P. P., Muriel M.-P., Ruberg M., Faucheux B. A., Agid Y., Hirsch E. C., Nuclear translocation of NF- b is increased in dopaminergic neurons of patients with Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America 1997 94 14 7531 7536 2-s2.0-0030842085 10.1073/pnas.94.14.7531 (Pubitemid 27345350)
16. Napolitano M., Zei D., Centonze D., Palermo R., Bernardi G., Vacca A., Calabresi P., Gulino A., NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease. Neuroscience Letters 2008 434 3 241 246 2-s2.0-40849123838 10.1016/j.neulet.2007.09.056
17. Hardie D. G., Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 2003 144 12 5179 5183 2-s2.0-0344081177 10.1210/en.2003-0982 (Pubitemid 37476044)
18. Abbott M. J., Edelman A. M., Turcotte L. P., CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle. The American Journal of Physiology: Regulatory Integrative and Comparative Physiology 2009 297 6 R1724 R1732 2-s2.0-72449131381 10.1152/ajpregu.00179.2009
19. Woods A., Johnstone S. R., Dickerson K., Leiper F. C., Fryer L. G. D., Neumann D., Schlattner U., Wallimann T., Carlson M., Carling D., LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Current Biology 2003 13 22 2004 2008 2-s2.0-10744230065 10.1016/j.cub.2003.10.031 (Pubitemid 37425212)
20. Hardie D. G., Hawley S. A., Scott J. W., AMP-activated protein kinase-development of the energy sensor concept. Journal of Physiology 2006 574 1 7 15 2-s2.0-33745225026 10.1113/jphysiol.2006.108944 (Pubitemid 43905792)
21. Galic S., Fullerton M. D., Schertzer J. D., Sikkema S., Marcinko K., Walkley C. R., Izon D., Honeyman J., Chen Z.-P., Van Denderen B. J., Kemp B. E., Steinberg G. R., Hematopoietic AMPK β 1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. Journal of Clinical Investigation 2011 121 12 4903 4915 2-s2.0-84055190798 10.1172/JCI58577
22. Park S. J., Lee K. S., Kim S. R., Chae H. J., Yoo W. H., Kim D. I., Jeon M. S., Lee Y. C., AMPK activation reduces vascular permeability and airway inflammation by regulating HIF/VEGFA pathway in a murine model of toluene diisocyanate-induced asthma. Inflammation Research 2012 61 10 1069 1083 2-s2.0-84867400434 10.1007/s00011-012-0499-6
23. Zhao X., Zmijewski J. W., Lorne E., Liu G., Park Y.-J., Tsuruta Y., Abraham E., Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. The American Journal of Physiology: Lung Cellular and Molecular Physiology 2008 295 3 L497 L504 2-s2.0-52649141738 10.1152/ajplung.90210.2008
24. Prasad R., Giri S., Nath N., Singh I., Singh A. K., 5-Aminoimidazole-4- carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction. Journal of Neuroscience Research 2006 84 3 614 625 2-s2.0-33746927979 10.1002/jnr.20953 (Pubitemid 44196702)
25. Giri S., Nath N., Smith B., Viollet B., Singh A. K., Singh I., 5-aminoimidazole-4-carboxamide-1- β -4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. Journal of Neuroscience 2004 24 2 479 487 2-s2.0-1642499162 10.1523/JNEUROSCI.4288-03.2004 (Pubitemid 38112379)
26. Chen H.-M., Lin J.-T., Kuo C.-Y., Huang C.-F., The effects of novel AMPK activator on human vascular endothelial cells. Journal of Medical and Bioengineering 2014 3 2 144 148 10.12720/jomb.3.2.144-148
27. Czapski G. A., Cakala M., Chalimoniuk M., Gajkowska B., Strosznajder J. B., Role of nitric oxide in the brain during lipopolysaccharide-evoked systemic inflammation. Journal of Neuroscience Research 2007 85 8 1694 1703 2-s2.0-34249830124 10.1002/jnr.21294 (Pubitemid 46849617)
28. Cantó C., Gerhart-Hines Z., Feige J. N., Lagouge M., Noriega L., Milne J. C., Elliott P. J., Puigserver P., Auwerx J., AMPK regulates energy expenditure by modulating NAD + metabolism and SIRT1 activity. Nature 2009 458 7241 1056 1060 2-s2.0-67349276169 10.1038/nature07813
29. Yang X.-D., Tajkhorshid E., Chen L.-F., Functional interplay between acetylation and methylation of the RelA subunit of NF- B. Molecular and Cellular Biology 2010 30 9 2170 2180 2-s2.0-77950642805 10.1128/MCB.01343-09
30. Yeung F., Hoberg J. E., Ramsey C. S., Keller M. D., Jones D. R., Frye R. A., Mayo M. W., Modulation of NF- B-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO Journal 2004 23 12 2369 2380 2-s2.0-3242719545 10.1038/sj.emboj.7600244 (Pubitemid 38954844)
31. Hattori Y., Suzuki K., Hattori S., Kasai K., Metformin inhibits cytokine-induced nuclear factor B activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 2006 47 6 1183 1188 2-s2.0-33744976813 10.1161/01.HYP.0000221429.94591.72 (Pubitemid 44289177)
32. Tsai S.-H., Lin-Shiau S.-Y., Lin J.-K., Suppression of nitric oxide synthase and the down-regulation of the activation of NF B in macrophages by resveratrol. British Journal of Pharmacology 1999 126 3 673 680 2-s2.0-0033023541 10.1038/sj.bjp.0702357 (Pubitemid 29087846)
33. Sarnico I., Boroni F., Benarese M., Alghisi M., Valerio A., Battistin L., Spano P., Pizzi M., Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. Journal of Neural Transmission 2008 115 5 693 701 2-s2.0-44749091716 10.1007/s00702-007-0016-1
34. Pizzi M., Sarnico I., Boroni F., Benetti A., Benarese M., Spano P. F., Inhibition of I B α phosphorylation prevents glutamate-induced NF- B activation and neuronal cell death. Acta Neurochirurgica 2005 93 59 63 2-s2.0-22844437957 10.1007/3-211-27577-0-8
35. Schwaninger M., Inta I., Herrmann O., NF- B signalling in cerebral ischaemia. Biochemical Society Transactions 2006 34 6 1291 1294 2-s2.0-33846563150 10.1042/BST0341291 (Pubitemid 46769040)
36. Zhang G., Li J., Purkayastha S., Tang Y., Zhang H., Yin Y., Li B., Liu G., Cai D., Hypothalamic programming of systemic ageing involving IKK- β NF- B and GnRH. Nature 2013 497 7448 211 216 2-s2.0-84877734347 10.1038/nature12143